Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Illumina Inc ILMN

Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company... see more

NDAQ:ILMN - Post Discussion

Illumina Inc > End of Month - August 2020
View:
Post by R_J_ on Sep 01, 2020 8:32am

End of Month - August 2020

End of the Month Report for August 2020 for Illumina Inc.
-
ILMN closed on 08/31/2020 at US$ 357.22
ILMN closed on 01731/2020 at US$ 382.16
-
This is a 6.5% loss, a US$ 24.94 loss, for August
-
S&P 500 Index, @ 3500.3 gained 7.0% in August. [13.5% above its MA(200) @ 3085.1]
-
Two Hundred Day Moving Average [MA(200)] stuff.
ILMN's  MA(200) ended August at US$324.52
ILMN is now 10.1% above its MA(200).
-
News Releases on the ILMN Website in August
-
Aug 25, 2020     
Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
-
Aug 7, 2020     
Illumina to Webcast Upcoming Investor Conference Presentation
-
Aug 6, 2020     
Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome
-
Aug 6, 2020     
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020
-
Who is in charge?
Francis A. DeSouza, CEO
-
RJ
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities